Skip to main content
Clinical Trials/ACTRN12612000247875
ACTRN12612000247875
Recruiting
Phase 4

Effect of the fixed versus unfixed combination of timolol and travoprost on intraocular pressure in 40 Caucasian patients with primary open angle glaucoma or ocular hypertension in 6 months follow up period.

uigi Mazzeo,Md0 sites40 target enrollmentFebruary 28, 2012

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Primary open angle glaucoma
Sponsor
uigi Mazzeo,Md
Enrollment
40
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 28, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
uigi Mazzeo,Md

Eligibility Criteria

Inclusion Criteria

  • Patients over 18 years with clinical diagnosis of primary open angle glaucoma or ocular hypertension who had been treated with any therapy

Exclusion Criteria

  • Abnormal corneal sensation, condition preventing tonometry, ocular opacity or insufficient dilation preventing retinal evaluation, narrow anterior chamber angle, inflammatory ocular surface disease, anterior/posterior uveitis, ocular inflammation/infection, progressive retinal disease, significant ocular signs/symptoms, allergic conjunctivitis, significant visual field defect or progressive visual field loss within the last year, history of certain ocular surgeries, significant cardiovascular disease, and history of pulmonary disease including asthma.

Outcomes

Primary Outcomes

Not specified

Similar Trials